Leaflet ARLEVERT 20mg / 40mg tablets


Indicated for: vertigo; vestibular disorders

Route of administration: oral

Substance: cinnarizine + dimenhydrinate (antihistamine + antiemetic)

ATC: N07CA52 (Nervous system | Antivertigo preparations)

Precautions:
Driving impairment
Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Glaucoma warning
Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Anticholinergic effects
Anticholinergic effects

May cause dry mouth, constipation, urinary retention, or blurred vision.

Drowsiness / sedation
Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

The combination of cinnarizine and dimenhydrinate is used for the treatment and prevention of balance disorders and associated symptoms such as dizziness, vertigo, nausea, and vomiting. It is commonly prescribed for vestibular conditions such as Ménière's disease or vertigo of central or peripheral origin.

Cinnarizine is a calcium channel blocker that improves blood circulation in the inner ear and reduces vestibular overstimulation. Dimenhydrinate is an antihistamine with antiemetic properties that reduces nausea and vomiting by blocking H1 receptors.

This combination is effective in relieving vertigo and nausea symptoms, providing a synergistic effect: cinnarizine addresses the cause of dizziness, while dimenhydrinate alleviates associated symptoms like nausea. It is recommended for both acute episodes and their prevention.

Side effects may include drowsiness, dry mouth, fatigue, headache, or gastrointestinal disturbances. In rare cases, allergic reactions, tremors, or confusion may occur, especially in elderly patients. Patients should avoid alcohol or other sedatives during treatment, as these may enhance drowsiness.

Patients should strictly follow their doctor’s instructions regarding dosage and treatment duration. It is also advised not to drive or operate heavy machinery while using this medication due to the risk of drowsiness.

ARLEVERT 20mg/40mg tablets HENNIG, cinnarizine+dimenhydrinate

General data about ARLEVERT 20mg / 40mg

  • Substance: cinnarizine + dimenhydrinate
  • Date of last drug list: 01-06-2026
  • Commercial code: W02144006
  • Concentration: 20mg / 40mg
  • Pharmaceutical form: tablets
  • Quantity: 48
  • Product type: original
  • Price: 59.74 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: HENNIG ARZNEIMITTEL GMBH & CO.KG - GERMANIA
  • Holder: HENNIG ARZNEIMITTEL GMBH & CO.KG - GERMANIA
  • Number: 11458/2019/05
  • Shelf life: 3 years

Compensation lists for ARLEVERT 20mg / 40mg Hennig

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

59.74 RON

29.31 RON

30.43 RON